DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay

Bitget2026/10/12 10:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DataMeds AI’s Helomics unit secured Medicaid coverage under Humana policy for its ChemoFx chemoresponse assay in gynecologic cancers.
Coverage took effect July 22, 2026 under Humana policy HUM-SC-2240-003, billed under CPT codes 81535 and 81536.
Eligibility centers on select clinical scenarios, including recurrence or treatment-refractory disease, supporting potential volume growth for Helomics’ CLIA lab.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610120600ACCESSWRNAPR_____1235643) on October 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay

You may also like

Crypto prices